Patent US4167467A successfully refreshed from Google Patents.
US4167467A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Clinical procedure for measuring lipoprotein free cholesterols
Assignee: Helena Laboratories Corp
•
Filing: 1978-07-26
•
Granted: 1979-09-11
•
Expires: 1998-07-26
Abstract
Abstract An electrophoresis method of determining the concentration of high density lipoprotein (HDL) free cholesterols in body fluids and simultaneously determining the concentration of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) free cholesterols in the fluid. The method includes applying a small sample of the fluid to an electrophoresis support medium, applying a direct current across the medium, applying a developing substrate to the electrophoresed lipoproteins and quantitatively determining the concentration of each lipoprotein free cholesterol. This method does permit direct and simultaneous measurement of each lipoprotein free cholesterol fraction while eliminating precipitation of each fraction as required by the prior art.
Inventors
- 👤 Tipton L. Golias
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 23:46
CPC Classifications
G; G01; G01N; G01N27/00; G01N27/26; G01N27/416; G01N27/447; G01N33/00; G01N33/48; G01N33/50; G01N33/92; G01N2800/00; G01N2800/04; G01N2800/044
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
134 words
A method of simultaneously determining the concentrations of high density lipoprotein free cholesterol, very low density lipoprotein free cholesterol and low density lipoprotein free cholesterol in a sample of body fluid, comprising the steps of: (a) applying a small sample of said body fluid to be tested to a solid electrophoresis support media strip, (b) applying a direct current for a predetermined period of time to said support media until the high density, very low density and low density lipoprotein free cholesterols have separated on the media, (c) applying a developing substrate sensitive to small concentrations of free cholesterol to the electrophoresed lipoprotein strip, and (d) quantitatively determining the concentrations of high density lipoprotein, very low density lipoprotein and low density lipoprotein free cholesterols in said body fluid sample from the developed electrophoresed sample.
Claim 2
Independent Claim
134 words
A method of simultaneously determining the concentrations of high density lipoprotein free cholesterol, very low density lipoprotein free cholesterol and low density lipoprotein free cholesterol in a sample of body fluid, comprising the steps of: (a) applying a small sample of said body fluid to be tested to a solid electrophoresis support media strip, (b) applying a direct current for a predetermined period of time to said support media until the high density, very low density and low density lipoprotein free cholesterols have separated on the media, (c) applying a developing substrate sensitive to small concentrations of free cholesterol to the electrophoresed lipoprotein strip, and (d) quantitatively determining the concentrations of high density lipoprotein, very low density lipoprotein and low density lipoprotein free cholesterols in said body fluid sample from the developed electrophoresed sample.
Claim 3
Dependent Claim
36 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid defined in claim 1, wherein said developing substrate is a cholesterol oxidase substrate which is applied to said electrophoresis support media.
Claim 4
Dependent Claim
42 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid defined in claim 2, wherein said cholesterol oxidase is applied to said support media by immersing the media in a fluid sample of said cholesterol oxidase reagent.
Claim 5
Dependent Claim
69 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid defined in claim 2, wherein said cholesterol oxidase substrate is applied to said support media by impregnating an untreated strip of support media with fluid cholesterol oxidase reagent and applying said impregnated strip to the electrophoresed lipoprotein free cholesterols in a sandwich form and incubating the sandwiched media for a predetermined period of time.
Claim 6
Dependent Claim
49 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid defined in claim 1, wherein said electrophoresis support media is cellulose acetate and said direct current is about one hundred eighty (180) volts which is applied to said support media for about twenty minutes.
Claim 7
Dependent Claim
47 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid defined in claim 1, wherein the concentrations of the lipoprotein free cholesterols are quantitatively determined by a densitometer by measuring absorbance of each lipoprotein free cholesterol following application of the developing substrate.
Claim 8
Dependent Claim
52 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid in claim 1, wherein said quantitative determination is made by eluting each electrophoresed fraction, including high density lipoprotein, very low density lipoprotein and low density lipoprotein free cholesterol and then quantitatively determining the concentration of each fraction.
Claim 9
Dependent Claim
30 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid defined in claim 7, wherein the concentration of each fraction is determined using a spectrophotometer.
Claim 10
Dependent Claim
40 words
The method of determining concentrations of lipoprotein free cholesters in a sample of body fluid defined in claim 7, wherein said cholesterol oxidase reagent is tagged with fluorescene, including quantitatively determining the concentration of each fraction by measuring the fluorescence.
Claim 11
Dependent Claim
48 words
The method of determining concentrations of lipoprotein free cholesterols in a sample of body fluid defined in claim 7, wherein said cholesterol oxidase is tagged with a radioactive isotope, including quantitatively determining the concentration of each fraction by measuring the radioactivity of each fraction with a radioisotope counter.
Claim 12
Independent Claim
101 words
A method of determining the concentration of high density lipoprotein free cholesterol in body fluid, comprising: (a) applying a small sample of said body fluid to a solid electrophoresis support media, (b) applying a direct current across said electrophoresis support media until the high density lipoprotein free cholesterol has separated from any remaining lipoprotein in said sample, (c) applying a developing substrate sensitive to high density lipoprotein free cholesterols to the separate electrophoresed high density lipoprotein free cholesterols, and (d) quantitatively determining the concentration of the high density lipoprotein free cholesterol present in said body fluid from said developed electrophoresed sample.
Claim 13
Independent Claim
101 words
A method of determining the concentration of high density lipoprotein free cholesterol in body fluid, comprising: (a) applying a small sample of said body fluid to a solid electrophoresis support media, (b) applying a direct current across said electrophoresis support media until the high density lipoprotein free cholesterol has separated from any remaining lipoprotein in said sample, (c) applying a developing substrate sensitive to high density lipoprotein free cholesterols to the separate electrophoresed high density lipoprotein free cholesterols, and (d) quantitatively determining the concentration of the high density lipoprotein free cholesterol present in said body fluid from said developed electrophoresed sample.
Claim 14
Dependent Claim
50 words
The method of determining the concentration of high density lipoprotein free cholesterol in a fluid sample defined in claim 11, wherein said developing substrate is a cholesterol oxidase substrate and said support media is cellulose acetate, including applying said cholesterol oxidase to the electrophoresed sample on said cellulose acetate media.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-09-10 | 1983-03-12 | 1983-09-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-09-10 | 1987-03-12 | 1987-09-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-09-10 | 1991-03-12 | 1991-09-11 | $7700.00 | Window Closed / Lapsed |